Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Abevmy Global Market Report 2025
Request Sample Buy Now
Global Abevmy Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Abevmy Global Market Report 2025

By Dose (100mg, 400mg), By Diseases (Cancer, Eye Diseases), By Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By End User (Hospitals, Cancer Supportive Centers, Academic And Research Institutes, Home Healthcare)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Abevmy Market?

Abevmy is a biosimilar version of the cancer drug bevacizumab, developed to offer a more affordable alternative while maintaining similar efficacy and safety. It works by targeting vascular endothelial growth factor (VEGF), a protein responsible for the formation of blood vessels that supply tumors with oxygen and nutrients. By inhibiting VEGF, Abevmy helps to prevent the growth of new blood vessels (angiogenesis), thereby limiting tumor growth and spread.

The main doses in the abevmy market are 100mg and 400mg. The 100 mg dose of abevmy is a specific formulation designed for patients requiring treatment for various cancers. The various diseases include cancer and eye diseases, and distribution channels including direct tender, hospital pharmacy, retail pharmacy, and online pharmacy. The end users encompass hospitals, cancer supportive centers, academic and research institutes, and home healthcare.

Abevmy Market Size and growth rate 2025 to 2029: Graph

What Is The Abevmy Market Size 2025 And Growth Rate?

The abevmy market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rising prevalence of cancer globally, increasing adoption of biosimilars in oncology treatment, growing demand for cost-effective cancer therapies, expanding approval of biosimilars for multiple oncology indications, and favorable regulatory policies supporting biosimilar adoption.

What Is The Abevmy Market Growth Forecast?

The abevmy market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising healthcare expenditure in emerging markets, increasing awareness about biosimilars among healthcare providers, growing geriatric population with higher cancer susceptibility, expansion of healthcare infrastructure in developing countries, and government initiatives to promote biosimilar usage. Major trends in the forecast period include product innovation, strategic partnerships, technological advancements, and growing investments in biosimilar research and development.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

How Is The Abevmy Market Segmented?

The abevmymarket covered in this report is segmented –

1) By Dose: 100mg, 400mg

2) By Diseases: Cancer, Eye Diseases

3) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

4) By End User: Hospitals, Cancer Supportive Centers, Academic And Research Institutes, Home Healthcare

What Is Driving The Abevmy Market? Rising Cancer Incidence Driving Growth Of The Abevmy Market

The increasing prevalence of cancer is expected to propel the growth of the abevmy market going forward. Cancer is influenced by a variety of factors, which can be broadly categorized into lifestyle choices, environmental exposures, and genetic predispositions. The increasing prevalence of cancer is due to a combination of factors, including an aging population, lifestyle changes such as poor diet, lack of physical activity, smoking, and alcohol consumption, as well as environmental exposures to carcinogens. Abevmy works by inhibiting vascular endothelial growth factor (VEGF), which reduces the formation of blood vessels that supply tumors with oxygen and nutrients, thus hindering their growth and spread. For instance, in January 2023, according to the American Cancer Society, a US-based non-profit cancer advocacy organization, the number of cancer cases increased to 1,958,310 in 2023, reflecting a growth of 3.16% from 1,898,160 in 2021. Thus, the increasing prevalence of cancer is driving the abevmy market.

Who Are The Major Players In The Global Abevmy Market?

Major companies operating in the abevmy market include Biocon Biologics Ltd., Viatris Inc.

What Are The Key Trends Of The Global Abevmy Market? Biosimilars Driving Innovation And Accessibility In The Abevmy Market

The key trend in the abevmy market is focusing on developing biosimilars to expand access to affordable biologic treatments, address unmet medical needs, and reduce healthcare costs. Biosimilars aim to provide cost-effective alternatives to originator biologics while maintaining similar efficacy, safety, and quality. For instance, in May 2022, Viatris, a US-based pharmaceutical company, and Biocon Biologics, a US-based pharmaceutical company, launched Abevmy (bevacizumab), which is a biosimilar similar to Roche’s Avastin (bevacizumab) in Canada. Abevmy has received approval from Health Canada for use across four oncology indications. Abevmy (Bevacizumab biosimilar) functions by binding to and inhibiting vascular endothelial growth factor (VEGF), a protein that promotes the development of blood vessels. This inhibition reduces the formation of new blood vessels (angiogenesis), which are essential for delivering oxygen and nutrients to tumors, thereby hindering their growth and spread.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Abevmy Market? Biocon Biologics Expands Market Leadership With Viatris Biosimilars Acquisition

In November 2022, Biocon Biologics Ltd., an India-based firm and subsidiary of Biocon Ltd., that manufactures biopharmaceuticals acquired Viatris Inc.’s global biosimilars business for an undisclosed amount. With this acquisition, Biocon Biologics aims to further strengthen its position in the biosimilars market. Viatris Inc. is a US-based pharmaceutical and healthcare company that deals in medicines for major therapeutic areas including cancer, including Bevacizumab.

What Is The Regional Outlook For The Global Abevmy Market?

North America was the largest region in the abevmy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the abevmy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the abevmy market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Abevmy Market?

The abevmy market consists of sales of intravenous (IV) infusion. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Abevmy Industry?

The abevmy market research report is one of a series of new reports from The Business Research Company that provides abevmy market statistics, including abevmy industry global market size, regional shares, competitors with a abevmy market share, detailed abevmy market segments, market trends, and opportunities, and any further data you may need to thrive in the abevmy industry. This abevmy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Abevmy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 Included !
Revenue Forecast In 2034 Included !
Growth Rate Included !
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Dose: 100mg, 400mg
2) By Diseases: Cancer, Eye Diseases
3) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By End User: Hospitals, Cancer Supportive Centers, Academic And Research Institutes, Home Healthcare
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Biocon Biologics Ltd., Viatris Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Abevmy Market Characteristics

3. Abevmy Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Abevmy Market Trends And Strategies

5. Abevmy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Abevmy Growth Analysis And Strategic Analysis Framework

6.1. Global Abevmy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Abevmy Market Growth Rate Analysis

6.4. Global Abevmy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

6.5. Global Abevmy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

6.6. Global Abevmy Total Addressable Market (TAM)

7. Global Abevmy Market Pricing Analysis & Forecasts

8. Abevmy Market Segmentation

8.1. Global Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

100mg

400mg

8.2. Global Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cancer

Eye Diseases

8.3. Global Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Direct Tender

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

8.4. Global Abevmy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Cancer Supportive Centers

Academic And Research Institutes

Home Healthcare

9. Global Abevmy Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Abevmy Market Regional And Country Analysis

10.1. Global Abevmy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. Global Abevmy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Abevmy Market

11.1. Asia-Pacific Abevmy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Asia-Pacific Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Asia-Pacific Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Abevmy Market

12.1. China Abevmy Market Overview

12.2. China Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.3. China Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.4. China Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Abevmy Market

13.1. India Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. India Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. India Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Abevmy Market

14.1. Japan Abevmy Market Overview

14.2. Japan Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. Japan Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. Japan Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Abevmy Market

15.1. Australia Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.2. Australia Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Australia Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Abevmy Market

16.1. South Korea Abevmy Market Overview

16.2. South Korea Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. South Korea Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.4. South Korea Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Abevmy Market

17.1. Western Europe Abevmy Market Overview

17.2. Western Europe Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Western Europe Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.4. Western Europe Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Abevmy Market

18.1. UK Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. UK Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. UK Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Abevmy Market

19.1. Germany Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Germany Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Germany Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Abevmy Market

20.1. France Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. France Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. France Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Abevmy Market

21.1. Eastern Europe Abevmy Market Overview

21.2. Eastern Europe Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Abevmy Market

22.1. North America Abevmy Market Overview

22.2. North America Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. North America Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.4. North America Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Abevmy Market

23.1. USA Abevmy Market Overview

23.2. USA Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. USA Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. USA Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Abevmy Market

24.1. Canada Abevmy Market Overview

24.2. Canada Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. Canada Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. Canada Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Abevmy Market

25.1. South America Abevmy Market Overview

25.2. South America Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. South America Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. South America Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Abevmy Market

26.1. Middle East Abevmy Market Overview

26.2. Middle East Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. Middle East Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. Middle East Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Abevmy Market

27.1. Africa Abevmy Market Overview

27.2. Africa Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Africa Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.4. Africa Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Abevmy Market Competitive Landscape And Company Profiles

28.1. Abevmy Market Competitive Landscape

28.2. Abevmy Market Company Profiles

28.2.1. Biocon Biologics Ltd. Overview, Products and Services, Strategy and Financial Analysis

28.2.2. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Abevmy Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Abevmy Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Abevmy Market

32. Recent Developments In The Abevmy Market

33. Abevmy Market High Potential Countries, Segments and Strategies

33.1 Abevmy Market In 2029 - Countries Offering Most New Opportunities

33.2 Abevmy Market In 2029 - Segments Offering Most New Opportunities

33.3 Abevmy Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Abevmy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Abevmy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Abevmy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Asia-Pacific, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: China, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: India, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Japan, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Australia, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: South Korea, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: South Korea, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: South Korea, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Western Europe, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Western Europe, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Western Europe, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: UK, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: UK, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: UK, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Germany, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Germany, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Germany, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: France, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: France, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: France, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Eastern Europe, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Eastern Europe, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Eastern Europe, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: North America, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: North America, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: North America, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: USA, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: USA, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: USA, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Canada, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Canada, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Canada, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: South America, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: South America, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: South America, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Middle East, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Middle East, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Middle East, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Africa, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Africa, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Africa, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Biocon Biologics Ltd. Financial Performance
  • Table 61: Viatris Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Abevmy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Abevmy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Abevmy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Asia-Pacific, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: China, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: India, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Japan, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Australia, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: South Korea, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: South Korea, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: South Korea, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Western Europe, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Western Europe, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Western Europe, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: UK, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: UK, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: UK, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Germany, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Germany, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Germany, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: France, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: France, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: France, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Eastern Europe, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Eastern Europe, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Eastern Europe, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: North America, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: North America, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: North America, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: USA, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: USA, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: USA, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Canada, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Canada, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Canada, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: South America, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: South America, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: South America, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Middle East, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Middle East, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Middle East, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Africa, Abevmy Market, Segmentation By Dose, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Africa, Abevmy Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Africa, Abevmy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Biocon Biologics Ltd. Financial Performance
  • Figure 61: Viatris Inc. Financial Performance

In-Depth Skin Booster Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Skin Booster Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving STAY-C For Feed Market

Read More About 2025 Analysis: Opportunities and Risks in the Evolving STAY-C For Feed Market

Global Insights: Sustained Release Excipients Market Expected to Surpass $2.1 Billion by 2029

Read More About Global Insights: Sustained Release Excipients Market Expected to Surpass $2.1 Billion by 2029

2025 Thalassemia Drugs Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Thalassemia Drugs Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Botanical Extracts Global Market Report 2025 – By Technology (CO2 Extraction, Solvent Extraction, Steam Distillation, Enfleurage, Other Technologies), By Source (Spices, Herbs, Flowers, Leaves, Other Sources), By Form (L...

View Report

Aerospace Couplers Global Market Report 2025 – By Type (Emergency Breakaway Coupler, Pressure Coupler, Hydrant Coupler), By Application (Commercial, Military) – Impact of Tariff and Trade War on Market Size, Growth, Tren...

View Report

Biosimilar Growth Hormones Global Market Report 2025 – By Route Of Administration (Intravenous, Subcutaneous, Intramuscular, Oral), By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Pr...

View Report

Biosimilar Hormones Global Market Report 2025 – By Type (Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars, Other Types), By Application (Research & Biotechnology, Diagno...

View Report

Biosimilar Interleukins Global Market Report 2025 – By Type (IL-17, IL-23, IL-1, IL-5, IL-6), By Application (Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease (IBD), Other Applicat...

View Report

Biosimilar Lymphocyte Modulator Global Market Report 2025 – By Drug (Campath-1H, Natalizumab Biosimilar, Efalizumab- A1089-Anti-CD11a Biosimilar, Anti-CD38 Daratumumab Biosimilar, Anti-CS1 Elotuzumab Biosimilar), By Dise...

View Report

Biosimilar Monoclonal Antibodies Global Market Report 2025 – By Type (Synthetic Chemicals, Biopharmaceuticals, Other Types), By Compound (Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab), By Applic...

View Report

Filgrastim Biosimilars Global Market Report 2025 – By Type Of Manufacturing (In-House Manufacturing, Contract Manufacturing organization), By Application (Oncology, Chronic And Autoimmune Diseases, Blood Disorders, Growt...

View Report

Frequently Asked Questions

Abevmy is a biosimilar version of the cancer drug bevacizumab, developed to offer a more affordable alternative while maintaining similar efficacy and safety. It works by targeting vascular endothelial growth factor (VEGF), a protein responsible for the formation of blood vessels that supply tumors with oxygen and nutrients. By inhibiting VEGF, Abevmy helps to prevent the growth of new blood vessels (angiogenesis), thereby limiting tumor growth and spread. For further insights on the Abevmy market, request a sample here

The Abevmy market major growth driver - Rising Cancer Incidence Driving Growth Of The Abevmy Market. For further insights on the Abevmy market, request a sample here

The Abevmy market size has grown strongly in recent years. The abevmy market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rising prevalence of cancer globally, increasing adoption of biosimilars in oncology treatment, growing demand for cost-effective cancer therapies, expanding approval of biosimilars for multiple oncology indications, and favorable regulatory policies supporting biosimilar adoption. The abevmy market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising healthcare expenditure in emerging markets, increasing awareness about biosimilars among healthcare providers, growing geriatric population with higher cancer susceptibility, expansion of healthcare infrastructure in developing countries, and government initiatives to promote biosimilar usage. Major trends in the forecast period include product innovation, strategic partnerships, technological advancements, and growing investments in biosimilar research and development. For further insights on the Abevmy market, request a sample here

The abevmymarket covered in this report is segmented –
1) By Dose: 100mg; 400mg
2) By Diseases: Cancer; Eye Diseases
3) By Distribution Channel: Direct Tender; Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
4) By End User: Hospitals; Cancer Supportive Centers; Academic And Research Institutes; Home Healthcare For further insights on the Abevmy market, request a sample here

North America was the largest region in the abevmy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the abevmy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Abevmy market, request a sample here.

Major companies operating in the abevmy market include Biocon Biologics Ltd., Viatris Inc. . For further insights on the Abevmy market, request a sample here.

Major trends in the Abevmy market include Biosimilars Driving Innovation And Accessibility In The Abevmy Market. For further insights on the Abevmy market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Abevmy Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top